Clinical Trial Update: Pyrotinib in Combination With Trastuzumab in Treatment-refractory, HER2-positive Metastatic Colorectal Cancar. [NA]

View source ↗

Summary

Clinical trial exploring the combination of pyrotinib with trastuzumab in treatment-refractory, HER2-positive metastatic colorectal cancer; the status and phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Pyrotinib (pyrotinib)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Colorectal Cancer | NA | Status: UNKNOWN